SABCS-话题@MedSci

#SABCS#

38篇内容 | 994人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1587483, encodeId=11cf158e483d3, content=<a href='/topic/show?id=e03515826f8' target=_blank style='color:#2F92EE;'>#SABCS#</a>, objectTitle=SABCS 2014：低脂饮食可延长ER-乳腺癌患者生存, objectType=article, longId=44404, objectId=871944404b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=871944404b0, replyNumber=0, likeNumber=21, createdTime=2014-12-24, rootId=0, userName=guguangxiang, userId=826117479684, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=871944404b0, moduleTitle=SABCS 2014：低脂饮食可延长ER-乳腺癌患者生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=871944404b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587482, encodeId=c776158e482cf, content=<a href='/topic/show?id=e03515826f8' target=_blank style='color:#2F92EE;'>#SABCS#</a>, objectTitle=SABCS 2014：Pembrolizumab使部分三阴性乳腺癌患者产生持续应答, objectType=article, longId=44049, objectId=e5794404941, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5794404941, replyNumber=0, likeNumber=25, createdTime=2014-12-16, rootId=0, userName=guguangxiang, userId=826117479684, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5794404941, moduleTitle=SABCS 2014：Pembrolizumab使部分三阴性乳腺癌患者产生持续应答, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5794404941)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587481, encodeId=b687158e481c2, content=<a href='/topic/show?id=e03515826f8' target=_blank style='color:#2F92EE;'>#SABCS#</a>, objectTitle=SABCS 2014：默沙东PD-1免疫疗法Keytruda展现三阴乳腺癌（TNBC）治疗潜力, objectType=article, longId=43990, objectId=6f7c43990df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f7c43990df, replyNumber=0, likeNumber=43, createdTime=2014-12-14, rootId=0, userName=guguangxiang, userId=826117479684, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f7c43990df, moduleTitle=SABCS 2014：默沙东PD-1免疫疗法Keytruda展现三阴乳腺癌（TNBC）治疗潜力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f7c43990df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587480, encodeId=b893158e48013, content=<a href='/topic/show?id=e03515826f8' target=_blank style='color:#2F92EE;'>#SABCS#</a>, objectTitle=SABCS 2013：亮点荟萃, objectType=article, longId=31252, objectId=cd233125266, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd233125266, replyNumber=0, likeNumber=25, createdTime=2014-02-28, rootId=0, userName=guguangxiang, userId=826117479684, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd233125266, moduleTitle=SABCS 2013：亮点荟萃, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd233125266)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587479, encodeId=4467158e47911, content=<a href='/topic/show?id=e03515826f8' target=_blank style='color:#2F92EE;'>#SABCS#</a>, objectTitle=SABCS 2013：带来的5大临床实践改变, objectType=article, longId=29495, objectId=ce2629495b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce2629495b7, replyNumber=0, likeNumber=48, createdTime=2014-01-18, rootId=0, userName=guguangxiang, userId=826117479684, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce2629495b7, moduleTitle=SABCS 2013：带来的5大临床实践改变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce2629495b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587478, encodeId=df31158e47871, content=<a href='/topic/show?id=e03515826f8' target=_blank style='color:#2F92EE;'>#SABCS#</a>, objectTitle=SABCS 2013：三阴性乳腺癌新辅助化疗获益, objectType=article, longId=28682, objectId=bebf28682da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bebf28682da, replyNumber=0, likeNumber=52, createdTime=2013-12-29, rootId=0, userName=guguangxiang, userId=826117479684, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bebf28682da, moduleTitle=SABCS 2013：三阴性乳腺癌新辅助化疗获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bebf28682da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587477, encodeId=acb5158e47740, content=<a href='/topic/show?id=e03515826f8' target=_blank style='color:#2F92EE;'>#SABCS#</a>, objectTitle=SABCS 2013：聚焦乳腺癌辅助治疗进展, objectType=article, longId=28681, objectId=afd92868195, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=afd92868195, replyNumber=0, likeNumber=32, createdTime=2013-12-29, rootId=0, userName=guguangxiang, userId=826117479684, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=afd92868195, moduleTitle=SABCS 2013：聚焦乳腺癌辅助治疗进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=afd92868195)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587476, encodeId=bd31158e4769f, content=<a href='/topic/show?id=e03515826f8' target=_blank style='color:#2F92EE;'>#SABCS#</a>, objectTitle=SABCS 2013：转移性乳腺癌靶向治疗新方法, objectType=article, longId=28680, objectId=22062868050, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22062868050, replyNumber=0, likeNumber=34, createdTime=2013-12-29, rootId=0, userName=guguangxiang, userId=826117479684, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22062868050, moduleTitle=SABCS 2013：转移性乳腺癌靶向治疗新方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=22062868050)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587475, encodeId=9364158e4759e, content=<a href='/topic/show?id=e03515826f8' target=_blank style='color:#2F92EE;'>#SABCS#</a>, objectTitle=SABCS 2013:聚焦乳腺癌领域的热点与进展, objectType=article, longId=28679, objectId=9025286e99e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9025286e99e, replyNumber=0, likeNumber=46, createdTime=2013-12-29, rootId=0, userName=guguangxiang, userId=826117479684, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9025286e99e, moduleTitle=SABCS 2013:聚焦乳腺癌领域的热点与进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9025286e99e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587474, encodeId=bf5e158e474bd, content=<a href='/topic/show?id=e03515826f8' target=_blank style='color:#2F92EE;'>#SABCS#</a>, objectTitle=SABCS：他汀类药物或可改善炎性乳腺癌PFS, objectType=article, longId=13095, objectId=198e13095a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=198e13095a6, replyNumber=0, likeNumber=35, createdTime=2012-12-19, rootId=0, userName=guguangxiang, userId=826117479684, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=198e13095a6, moduleTitle=SABCS：他汀类药物或可改善炎性乳腺癌PFS, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=198e13095a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587473, encodeId=2ac6158e47364, content=<a href='/topic/show?id=e03515826f8' target=_blank style='color:#2F92EE;'>#SABCS#</a>, objectTitle=SABCS：乳腺癌内分泌治疗的3项重磅研究, objectType=article, longId=13094, objectId=b11513094b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b11513094b0, replyNumber=0, likeNumber=30, createdTime=2012-12-19, rootId=0, userName=guguangxiang, userId=826117479684, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b11513094b0, moduleTitle=SABCS：乳腺癌内分泌治疗的3项重磅研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b11513094b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587472, encodeId=98c0158e47294, content=<a href='/topic/show?id=e03515826f8' target=_blank style='color:#2F92EE;'>#SABCS#</a>, objectTitle=SABCS：乳腺癌预后指标的意外之喜—维生素D, objectType=article, longId=12976, objectId=0361129e6c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0361129e6c5, replyNumber=0, likeNumber=27, createdTime=2012-12-14, rootId=0, userName=guguangxiang, userId=826117479684, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0361129e6c5, moduleTitle=SABCS：乳腺癌预后指标的意外之喜—维生素D, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0361129e6c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587471, encodeId=b8f8158e471b5, content=<a href='/topic/show?id=e03515826f8' target=_blank style='color:#2F92EE;'>#SABCS#</a>, objectTitle=SABCS：负荷剂量氟维司群效果更优, objectType=article, longId=12975, objectId=9bf5129e596, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9bf5129e596, replyNumber=0, likeNumber=45, createdTime=2012-12-14, rootId=0, userName=guguangxiang, userId=826117479684, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9bf5129e596, moduleTitle=SABCS：负荷剂量氟维司群效果更优, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9bf5129e596)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587470, encodeId=5dba158e47052, content=<a href='/topic/show?id=e03515826f8' target=_blank style='color:#2F92EE;'>#SABCS#</a>, objectTitle=SABCS：表阿霉素加速剂量未使乳腺癌患者获益, objectType=article, longId=12840, objectId=eaab12840d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eaab12840d6, replyNumber=0, likeNumber=43, createdTime=2012-12-12, rootId=0, userName=guguangxiang, userId=826117479684, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eaab12840d6, moduleTitle=SABCS：表阿霉素加速剂量未使乳腺癌患者获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eaab12840d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587469, encodeId=73bc158e4698a, content=<a href='/topic/show?id=e03515826f8' target=_blank style='color:#2F92EE;'>#SABCS#</a>, objectTitle=SABCS：专家聚焦圣安东尼奥大会热点, objectType=article, longId=12839, objectId=b11f12839f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b11f12839f7, replyNumber=0, likeNumber=35, createdTime=2012-12-12, rootId=0, userName=guguangxiang, userId=826117479684, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b11f12839f7, moduleTitle=SABCS：专家聚焦圣安东尼奥大会热点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b11f12839f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587468, encodeId=3ea3158e468d5, content=<a href='/topic/show?id=e03515826f8' target=_blank style='color:#2F92EE;'>#SABCS#</a>, objectTitle=SABCS：乳腺癌贝伐单抗治疗走向终点？, objectType=article, longId=12838, objectId=7ee712838a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ee712838a8, replyNumber=0, likeNumber=32, createdTime=2012-12-12, rootId=0, userName=guguangxiang, userId=826117479684, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ee712838a8, moduleTitle=SABCS：乳腺癌贝伐单抗治疗走向终点？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ee712838a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587467, encodeId=f66a158e46776, content=<a href='/topic/show?id=e03515826f8' target=_blank style='color:#2F92EE;'>#SABCS#</a>, objectTitle=SABCS：艾日布林用于晚期乳腺癌可与卡培他滨相媲美, objectType=article, longId=12837, objectId=5bfe1283efa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5bfe1283efa, replyNumber=0, likeNumber=39, createdTime=2012-12-12, rootId=0, userName=guguangxiang, userId=826117479684, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5bfe1283efa, moduleTitle=SABCS：艾日布林用于晚期乳腺癌可与卡培他滨相媲美, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5bfe1283efa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587466, encodeId=092d158e46629, content=<a href='/topic/show?id=e03515826f8' target=_blank style='color:#2F92EE;'>#SABCS#</a>, objectTitle=SABCS：乳腺癌干细胞对抗化疗和放疗的机制被初步揭开, objectType=article, longId=3537, objectId=093b353eed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=093b353eed, replyNumber=0, likeNumber=40, createdTime=2011-12-22, rootId=0, userName=guguangxiang, userId=826117479684, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=093b353eed, moduleTitle=SABCS：乳腺癌干细胞对抗化疗和放疗的机制被初步揭开, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=093b353eed)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

SABCS

2020-05-29

guguangxiang (审核中...)

前往app查看评论内容

#SABCS#

SABCS 2014：低脂饮食可延长ER-乳腺癌患者生存

2014-12-24

guguangxiang (审核中...)

前往app查看评论内容

#SABCS#

SABCS 2014：Pembrolizumab使部分三阴性乳腺癌患者产生持续应答

2014-12-16

guguangxiang (审核中...)

前往app查看评论内容

#SABCS#

SABCS 2014：默沙东PD-1免疫疗法Keytruda展现三阴乳腺癌（TNBC）治疗潜力

2014-12-14

guguangxiang (审核中...)

前往app查看评论内容

#SABCS#

SABCS 2013：亮点荟萃

2014-02-28

guguangxiang (审核中...)

前往app查看评论内容

#SABCS#

SABCS 2013：带来的5大临床实践改变

2014-01-18

guguangxiang (审核中...)

前往app查看评论内容

#SABCS#

SABCS 2013：三阴性乳腺癌新辅助化疗获益

2013-12-29

guguangxiang (审核中...)

前往app查看评论内容

#SABCS#

SABCS 2013：聚焦乳腺癌辅助治疗进展

2013-12-29

guguangxiang (审核中...)

前往app查看评论内容

#SABCS#

SABCS 2013：转移性乳腺癌靶向治疗新方法

2013-12-29

guguangxiang (审核中...)

前往app查看评论内容

#SABCS#

SABCS 2013:聚焦乳腺癌领域的热点与进展

2013-12-29

guguangxiang (审核中...)

前往app查看评论内容

#SABCS#

SABCS：他汀类药物或可改善炎性乳腺癌PFS

2012-12-19

guguangxiang (审核中...)

前往app查看评论内容

#SABCS#

SABCS：乳腺癌内分泌治疗的3项重磅研究

2012-12-19

guguangxiang (审核中...)

前往app查看评论内容

#SABCS#

SABCS：乳腺癌预后指标的意外之喜—维生素D

2012-12-14

guguangxiang (审核中...)

前往app查看评论内容

#SABCS#

SABCS：负荷剂量氟维司群效果更优

2012-12-14

guguangxiang (审核中...)

前往app查看评论内容

#SABCS#

SABCS：表阿霉素加速剂量未使乳腺癌患者获益

2012-12-12

guguangxiang (审核中...)

前往app查看评论内容

#SABCS#

SABCS：专家聚焦圣安东尼奥大会热点

2012-12-12

guguangxiang (审核中...)

前往app查看评论内容

#SABCS#

SABCS：乳腺癌贝伐单抗治疗走向终点？

2012-12-12

guguangxiang (审核中...)

前往app查看评论内容

#SABCS#

SABCS：艾日布林用于晚期乳腺癌可与卡培他滨相媲美

2012-12-12

guguangxiang (审核中...)

前往app查看评论内容

#SABCS#

SABCS：乳腺癌干细胞对抗化疗和放疗的机制被初步揭开

2011-12-22

科室
- - 订阅+
  - 更多科室
工具
服务